Enliven Therapeutics, Inc. (ELVN) Earnings
NASDAQ·Healthcare·Biotechnology
$54.42
-3.22%
Mkt Cap $4.24B
EPS — Estimate vs Actual
Mkt Cap
$4.24B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.64
NASDAQ·Healthcare·Biotechnology
$54.42
-3.22%
Mkt Cap $4.24B
Mkt Cap
$4.24B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.64